VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1740422
Sex: F
Age:
State: IL

Vax Date: 02/25/2021
Onset Date:
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Blood work; Result Unstructured Data: Test Result:Everything was under control

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: she just had a sore arm; her arm was was a little red, puffy, and a little warm; her arm was was a little red, puffy, and a little warm; her arm was was a little red, puffy, and a little warm; Use to be 5'2 now she is about 5'1 she shrunk.; it is blotchy but the redness is about gone now it has been 3 weeks; This is a spontaneous report from a contactable consumer (patient). A 80-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6205, Expiration date: unknown) via an unspecified route of administration on 25Feb2021 (at the age of 80-year-old) as dose 1, single for covid-19 immunisation. Medical history included atrial fibrillation from an unknown date and unknown if ongoing, patient stated in May2019 she had severe cold and cough, she was sick for 3 weeks, she lost her sense of smell for 3 months unknown if ongoing, in Jan2020 , patient had a sore arm for 3 days with the shingles shot. The patient's concomitant medications were not reported. Patient stated she is borderline she thinks but she thinks they done blood work and everything was under control so she imagines she was not actually diabetic she was not over the line, not considered diabetic, she just needs to watch what she eats and stay away. On an unspecified date, patient had sore arm, her arm was just red puffy and a little warm, the redness is finally fading after 3 weeks, it is blotchy but the redness is about gone now it has been 3 weeks, patient stated she used to be 5 feet 2 in now she is about 5 feet 1 in she shrunked. Outcome of event use to be 5'2 now she is about 5'1 she shrunk was unknown and outcome of rest all events was recovered on an unspecified date of 2021. No follow-up attempts are needed. No further information is expected

Other Meds:

Current Illness:

ID: 1740423
Sex: M
Age:
State: AL

Vax Date:
Onset Date:
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: rash at the injection site; pain in shoulder; This is a spontaneous report from a contactable consumer (patient) received via Pfizer. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient stated that he developed rash at the injection site after getting the shot and has pain in shoulder. The clinical outcome for the events was unknown. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1740424
Sex: M
Age:
State: NY

Vax Date: 03/11/2021
Onset Date: 03/01/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Sore throat; chest discomfort; This is a spontaneous report from a contactable consumer via a Pfizer sales representative. This consumer reported for a male patient. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: Unknown), via an unspecified route of administration on 11Mar2021, as dose 1, single for COVID-19 immunisation at hospital. Medical history included fear of exposure to COVID-19 virus. Concomitant medications were not reported. On an unspecified date in Mar2021, since first dose, the patient experienced sore throat and chest discomfort for a week. Events took place after use of suspect vaccine product. The clinical outcome of both the events was resolved on unspecified dates in Mar2021. No follow-up attempts were possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1740425
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: chills; slight fever; tiredness/Still a little tired; headache; some brain fog; This is a spontaneous report from a contactable consumer (patient). A 59-years-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EL3247), via an unspecified route on unspecified date as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On unspecified date (12 hours after vaccination), the patient experienced chills, slight fever, tiredness and headache. This continued for about 36 hours and after that patient feeling better. Patient had still a little tired and some brain fog. Patient reported that no underlying medical conditions and general good health. The outcome of the events was recovering. No follow-up attempts are possible. No further information is expected. Follow-up (18Mar2021): This follow-up contains no new significant medical information.

Other Meds:

Current Illness:

ID: 1740426
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: fever; Result Unstructured Data: Test Result:38.0 C; Comments: resolved within 48 hours

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: 38.0 C fever; malaise; generalized fatigue; muscle cramps; chills; headache; general myalgia; injection site pain; mild exacerbation of underlying allergic asthma; mild exacerbation of underlying allergic asthma; This is a spontaneous report from a contactable consumer or other non-health care professional. A patient of unspecified age and gender received BNT162B2, (BNT162B2, formulation: Solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history included allergic asthma. The patient had no concomitant medications. Historical vaccine included BNT162B2 (BNT162B2, formulation: Solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient experienced 38.0 c fever, malaise, generalized fatigue, muscle cramps, chills, headache, general myalgia, injection site pain, mild exacerbation of underlying allergic asthma on an unspecified date and all resolved within 48 hours. The patient underwent lab tests and procedures which included pyrexia: 38.0 c on resolved within 48 hours. The outcome of the events was recovered on unspecified date. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1740427
Sex: M
Age:
State: CA

Vax Date: 03/16/2021
Onset Date: 03/17/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Soreness at site of injection; mild chills; mild fever; mild fatigue; mild ache in shoulder joints; heavy headedness; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 51-years-old male patient received second dose of bnt162b2 (BNT162B2, Solution for injection, Lot Number: EN6199), via an unspecified route of administration, administered in Arm Left on 16Mar2021 15:30 as DOSE 2, SINGLE for covid-19 immunization (age at vaccination 51 years). Medical history included myocardial infarction from 2015 to an unknown date, allergy to Bee sting from an unknown date and unknown if ongoing. Concomitant medications included atorvastatin (ATORVASTATIN), ezetimibe (EZETIMIBE), diltiazem (DILTIAZEM) and losartan (LOSARTAN); all taken for an unspecified indication, start and stop dates were not reported. The patient previously received first dose of bnt162b2 (BNT162B2, Solution for injection, Lot Number: EN5318), via an unspecified route of administration, administered in Arm Left on 24Feb2021 13:15 as DOSE 1, SINGLE for covid-19 immunization. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not tested for COVID-19. The patient experienced soreness at site of injection, mild chills, mild fever, mild fatigue, mild ache in shoulder joints, heavy headedness on 17Mar2021 15:00. Patient did not received treatment for adverse events. It was reported that, the patient became aware of the adverse events 24 hours after receiving 2nd dose of the vaccine. I received my dose on March 16th, 2021 and became aware of the adverse events on March 17th, 2021. The outcome the events was recovered on an unspecified date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1740428
Sex: F
Age:
State: TN

Vax Date: 03/26/2021
Onset Date: 03/29/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: My arm started feeling tender later in the day of the shot; swelling under my armpit. It looks like a lump; This is a spontaneous report from a contactable consumer (patient). A 49-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EP6955 and expiration date: not reported), via an unspecified route of administration, administered in Right Arm, on 26Mar2021 at 11:00 (at the age of 49-year-old) as DOSE 2, SINGLE for covid-19 immunization in Workplace clinic.The patient medical history was not reported. Concomitant medication included ibuprofen (ADVIL 12 HOUR). Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3248 and expiration date: not reported), via an unspecified route of administration, administered in Right Arm, on 05Mar2021 at 11:00 (at the age of 49-year-old) as DOSE 1, SINGLE for covid-19 immunization.The patient was not pregnant at time of vaccination. The patient didn't receive any other vaccines within 4 weeks prior to the COVID -19 vaccine. The Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. On 29Mar2021 at 11:00, the patient's arm started feeling tender later in the day of the shot, that continued, but patient thought nothing of it as patient was told that should be expected. Now the patient saw there is swelling under her armpit. It looked like a lump. The patient waited to see if it would get better. It had, but it was still noticeable. The patient hoping it would continue on the path of feeling better and the swelling/lump going away. No treatment was received for the adverse event. The outcome of the events was recovering at time of report. No follow-up attempts are needed. No further information is expected.

Other Meds: Pfizer EUA 027034

Current Illness:

ID: 1740429
Sex: F
Age:
State: TX

Vax Date: 03/31/2021
Onset Date: 04/01/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: My body is very ache; muscles are killing me; extreme headache; vomited; can't walk well; chills; hot flashes; extreme tiredness; arm where I got the shot is killing me; can't move my arm around; my brain and memory is fogy; I have very bad coordination; This is a spontaneous report from a contactable health care professional (HCP) (patient). A 35-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Expiration date: Not reported), via an unspecified route of administration in right arm, on 31Mar2021 at 15:00 (at the age of 35-years-old) as dose 1, single for COVID-19 immunization in a public health clinic. No patient's other medical history was reported. The patient was allergic to penicillin and bee stings. There were no concomitant medications/any other medications the patient received within 2 weeks of vaccination. The patient was not pregnant at the time of vaccination and didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. The patient's body was very ache, muscles were killing her, extreme headache, vomited, can't walk well, chills, hot flashes, extreme tiredness, arm where she got the shot is killing her, can't move her arm around, brain and memory was foggy and the patient had very bad coordination on 01Apr2021 at 07:00. It was unknown if the patient received treatment for these events. The patient was not recovered for these events at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1740430
Sex: M
Age:
State:

Vax Date: 03/01/2021
Onset Date:
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: low grad fever; Result Unstructured Data: Test Result:around 99 point

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: heart seemed to be racing; Rash; muscle aches; tiredness; low grade fever; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date in Mar2021 as dose 1, single for COVID-19 immunisation. Medical history included historical allergic reaction to Penicillin and also got itchy over 40 years ago. The patient's concomitant medications were not reported. After first dose of vaccination, patient experienced mild symptoms, including, muscle aches, tiredness, a low grade fever which was around 99 point something. He took ibuprofen and went to bed. It lasted for 12 hours. But on an unspecified date, his heart seemed to be racing for first few hours and had a rash on his body. Patient asked if that was a severe reaction and does it prevent him or contraindicate him from getting the second vaccine dose. It was also reported that that he already informed his primary care physician and physician wasn't sure and advised him to call Pfizer to speak with a medical professional. The outcome of the events his heart seemed to be racing for first few hours and had a rash on his body was unknown and of all other events was recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1740431
Sex: M
Age:
State: FL

Vax Date: 03/30/2021
Onset Date: 03/31/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: rash/hives on my neck and arms; rash/hives on my neck and arms; This is a spontaneous report from a contactable consumer(patient). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot number was not reported), via an unspecified route of administration on 30Mar2021 as dose number unknown, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced rash/hives on his neck and arms on 31Mar2021. The outcome was unknown for the reported events. No follow-up attempts are possible. Information on batch/lot number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1740432
Sex: F
Age:
State: ND

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: swollen injection site with redness; swollen injection site with redness; swollen lymph nodes in armpit and neck; earache; fever of 102; joint pain; fatigue; nausea; diarrhea; headache; loss of smell and taste; loss of smell and taste; This is a spontaneous report from a non-contactable consumer (patient). A 48-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EP7533), via an unspecified route of administration in left arm on 30Mar2021 (at the age of 48-years-old) as dose 2, single for COVID-19 immunization. Medical history included Obesity and Penicillin allergy. Concomitant medication included ascorbic acid, ergocalciferol, folic acid, nicotinamide, panthenol, retinol, riboflavin, thiamine hydrochloride (MULTIVITAMINS) and calcium. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6204), via an unspecified route of administration on 09Mar2021 09:30 (at the age of 48-years-old) as dose 1, single for COVID-19 immunization. Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive any vaccines within four weeks and was not pregnant. The patient experienced swollen injection site with redness, swollen lymph nodes in armpit and neck, earache, fever of 102, joint pain, fatigue, nausea, diarrhea, headache and loss of smell and taste on 30Mar2021. Since the vaccination, patient has not been tested for COVID-19. No treatment was received for the event. Outcome of events was not resolved. No follow-up attempts are possible. No further information is expected.

Other Meds: Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034

Current Illness:

ID: 1740433
Sex: F
Age:
State: TX

Vax Date: 03/08/2021
Onset Date:
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 40-year-old female patient received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# EN6205), at the age of 40, via an unspecified route of administration, left arm, on Mar 8, 2021, at 17:30, single dose, for COVID-19 immunization. The patient was not pregnant at the time of vaccination. Medical history included obesity and COVID-19 (prior to vaccination). The patient's concomitant medications: none. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took penicillin and experienced allergies. The patient experienced arm pain, swollen lymph node and fever on an unspecified date. The patient did not receive any treatment for the events. The outcome of the events: recovering. Since the vaccination, patient has not tested for COVID-19. No follow-up attempts needed. No further information expected.

Other Meds:

Current Illness:

ID: 1740434
Sex: U
Age:
State: AL

Vax Date: 02/19/2021
Onset Date: 02/19/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: flu like symptoms; body ache; chills; sweats; joint pain; fever; This is a spontaneous report from a contactable consumer (patient). A 37-year-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EN6200), intramuscular, administered in right arm on 19Feb2021 08:00 (at the age of 37 year old) as dose 2, single for COVID-19 immunisation. Medical history included ongoing lupus from 2017. Concomitant medications included ongoing bupropion hydrochloride (WELLBUTRIN) for depression from 2017; lisinopril from 2017 and metoprolol from 2020, both for high BP. Prior vaccination, patient did not receive any other vaccines within four weeks. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9262), intramuscular, administered in left arm on 29Jan2021 08:00 (at the age of 37 year old) as single dose for COVID-19 immunization and the patient experienced swelling on 05Feb2021 08:00. On 19Feb2021 23:00, the patient had fever and joint pain and on an unspecified date, patient had Flu like symptoms, body ache, chills and sweats. No relevant tests and treatment was initiated in response to the events. The outcome of the events was recovered. No follow-up attempts are needed. No further information is expected.

Other Meds: Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034

Current Illness: Lupus syndrome

ID: 1740435
Sex: M
Age:
State: MO

Vax Date: 03/26/2021
Onset Date:
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: fatigue; Fever; This is a spontaneous report from a contactable consumer (daughter). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number was not reported), via an unspecified route of administration on 26Mar2021 as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number was not reported), via an unspecified route of administration on 04Mar2021 as dose 1, single for covid-19 immunisation. The patient has experienced fatigue and fever during nighttime for 3 days now. The outcome of event was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1740436
Sex: M
Age:
State: PA

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: painful wrist/ right hand was hurting very bad/joint is swollen with severe pain; joint is swollen with severe pain; felt very cold; arm hurt at the injection site; This is a spontaneous report from a contactable consumer (patient). A 66-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 30Mar2021 (at the age of 66-years-old) as dose 2, single for covid-19 immunization. Medical history included acid reflux. The patient had no concomitant medications. Patient historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Batch/Lot number was not reported), via an unspecified route of administration on 09Mar2021 (at the age of 66-years-old) as dose 1, single for covid-19 immunization. The patient had a little pain in arm where the vaccine was injected on the day of vaccination. On the second night the patient felt very cold. This morning when he woke up his right hand was hurting very bad where he had put his watch and the joint was swollen with severe pain. The outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1740437
Sex: U
Age:
State: AK

Vax Date:
Onset Date:
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Rash on the buttocks or upper thigh, ecchymotic appearance; Rash on the buttocks or upper thigh, ecchymotic appearance; This is a spontaneous report from a contactable nurse reporting same event under the same suspect product for four patients. This is one of four reports. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Lot number and expiration date was not reported) as dose number unknown, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced rash on the buttocks or upper thigh, ecchymotic appearance on an unspecified date. The rash begins with an appearance similar to shingles. After about a week the lesions are flat with an ecchymotic appearance. The outcome of event was unknown. No follow-up attempts are needed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021375425 same drug, event, different patient; US-PFIZER INC-2021375443 same drug, event, different patient

Other Meds:

Current Illness:

ID: 1740438
Sex: F
Age:
State: OH

Vax Date: 04/05/2021
Onset Date: 04/05/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: lump like a golf ball on her arm; second dose was unrefrigerated; second dose was unrefrigerated; Experienced swelling of the left arm; pain on the injection site; there's blood when she took of the band aid; This is a spontaneous report from a contactable consumer (patient). A 74-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: ER2613 and Expiration Date: 13Jul2021), via an unspecified route of administration, on 05Apr2021 at 11:30 (at the age of 74-year-old) as DOSE 2, SINGLE for covid-19 immunization. Medical history included stroke from Sep2020 and Kidney stones from Feb2020. The patient had no concomitant medications. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6204 and Expiration Date: 30 Jun 2021), via an unspecified route of administration, on left arm, on 08Mar2021 at 11:30 (at the age of 74-year-old) as DOSE 1, SINGLE for covid-19 immunization. The patient not had any other recent vaccinations. The patient experienced swelling of the left arm, pain on the injection site and there's blood when patient took of the band aid on 2021. The patient had a lump like golf ball on her arm, on 05Apr2021. The patient further stated that she also thought the vaccine had to be refrigerated, but the person had syringes sitting on the desk, which was different from the first time, when they pulled from fridge to give shot. The Patient noticed that the vaccines being administered in the vaccination site were not in the refrigerator. The patient would like to know if she can have pain relievers like Advil to ease the pain and also Asking if it is ok for the vaccines to stay in the room temperature. The patient would like to know what can she use, Motrin, Aspirin, or Aleve. The patient said, she would like to get the swelling down, she put some heat on the area first which didn't work so she used ice and had more relief from ice. The patient said she doesn't want to have gone thru all this and her vaccine not work because the second dose was four weeks and was unrefrigerated. The patient stated she would also like to know how long the vaccines are allowed to be unrefrigerated if they are allowed to be. Therapeutic measures were taken as a result of event swelling of the left arm included heat and ice. The outcome of the events was unknown at time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1740439
Sex: F
Age:
State: NY

Vax Date: 03/22/2021
Onset Date: 03/24/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Name: COVID-19 test; Test Result: Negative.

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: This is a spontaneous report from a contactable consumer (patient). A female patient, of an unspecified age, received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# not reported), via an unspecified route of administration, on Mar 22, 2021, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. On Mar 24, 2021, she developed a rash all over her body. It itched. She kept on scratching. On Mar 28, 2021, she went to a clinic. They prescribed her a steroid to take along with Benadryl. The physician informed her the steroid would interfere with the COVID-19 vaccine; so she took Benadryl, and put on Cortisone-10, which helped with the itching. At the time of report, she still had the rash. That day was the first day the itching was not so bad as before. She had a scheduled appointment for a second dose due on Apr 12, 2021. She asked if this would happen again or worst if she got her second dose. The patient has tested for COVID-19 several times, and results were negative. The outcome of the events: recovering. No follow-up attempts possible. Information about lot/batch number cannot be obtained. No further information expected.

Other Meds:

Current Illness:

ID: 1740440
Sex: F
Age:
State: MT

Vax Date: 02/17/2021
Onset Date: 02/17/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Really tired achie; Joints ached very bad; very tired; had chills; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EL9266), intramuscular, administered in Left arm on 17Feb2021 10:40 as dose 2, single for COVID-19 immunisation. Medical history included Type 2 Diabetes and Cholesterol. Concomitant medications included ongoing lisinopril; choline fenofibrate (TRILIPIX); metformin, all for type 2 diabetes and cholesterol; magnesium chloride (SLOW-MAG); multivitamins and alene, all for an unspecified indication. Patient had no prior vaccinations. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL8982) , Intramuscular, in left arm, on 21Jan2021 10:40, as single dose for COVID-19 immunization and on 05Feb2021, the patient experienced night sweats, shortness of breath, tired more so than usual. On 17Feb2021 20:00, the patient experienced very tired and had chills and on 18Feb2021 18:00, she was really tired, achie and joints ached very bad. Therapeutic measures were taken in response to the events included, Tylenol. It was reported that she seemed okay in the morning. The outcome of the event had chills was unknown and of other events was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness: Cholesterol; Type 2 diabetes mellitus

ID: 1740441
Sex: F
Age:
State: MA

Vax Date: 04/06/2021
Onset Date: 04/06/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Lip swelling; facial swelling and Cheek swelling; This is a spontaneous report from a contactable consumer (patient). A 68-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiration date: not reported), via an unspecified route of administration, on 06Apr2021, as DOSE 1, SINGLE for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On 06Apr2021, an hour after the vaccine, the patient noticed her cheeks felt they were swelling. On 7Apr2021, the patient had minor swelling on her lips. The patient would like to know, if this is a common side effect after the vaccine. The outcome of the events was unknown at time of report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1740442
Sex: F
Age:
State: NJ

Vax Date: 03/08/2021
Onset Date: 03/09/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: after the vaccine she is only getting like 2 good days out of her infusions, making the infusions not help now; after the vaccine she is only getting like 2 good days out of her infusions, making the infusions not help now; severe lethargy and malaise; severe lethargy and malaise; severe neck pain; smells things burning; no appetite; tinnitus in both ears; chest pains; lost a lot of weight; This is a spontaneous report from a contactable nurse (patient). A 65-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 08Mar2021 (at the age of 65-years-old) as dose 2, single for covid-19 immunization . Medical history included ongoing Primary immune deficiency disease diagnosed around 2017. States she has multiple drug allergies, no further information provided. Concomitant medication included immunoglobulin human normal (GAMMAPLEX) taken for an primary immune deficiency disease from 2018. Patient historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number: EL9266), via an unspecified route of administration, administered in Arm Left on 15Feb2021 (at the age of 65-years-old) as dose 2, single for covid-19 immunization Patient state she was lethargic and had severe malaise, she had severe neck pain and had to ice things, states she smells things burning all the time, the house burning, toast burning, stopped checking because she knows it was just a symtom, she had no appetite, had tinnitus in both ears and now it is unbearable, can barely hear because it is so loud in both ears, has chest pains that she has never had before, and states after the vaccine she was only getting like 2 good days out of her infusions, it had decreased the effectiveness of the infusions, used to get a good 10 days after the infusions, now she only gets 2. States she has lost a lot of weight as well since the second dose of the vaccine, used to be 175. The outcome of the events was not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: Pfizer, Inc. EUA 027034

Current Illness: Immune system disorder (Verbatim: Primary immune deficiency disease)

ID: 1740443
Sex: U
Age:
State:

Vax Date: 03/27/2021
Onset Date: 03/30/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Bad joint and muscle pain in my left leg; Bad joint and muscle pain in my left leg; poking me with the pin on my chin and my left chin also.; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: unknown and expiration date: not reported), via an unspecified route of administration, on 27Mar2021, as DOSE 1, SINGLE for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On 30Mar2021, 3 days after the vaccination, the patient experienced bad joint and muscle pain in left leg, patient had got like someone is poking patient with the pin on chin and left chin also. The patient would like to know if that was normal. The outcome of the events was unknown at time of report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1740444
Sex: F
Age:
State: CA

Vax Date: 04/10/2021
Onset Date: 04/10/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Rash on my neck and upper chest within 6 hrs of vaccine; Rash on neck burns; This is a spontaneous report from a contactable consumer (patient). A 59-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EW0162), via an unspecified route of administration, administered in Right arm on 10Apr2021 14:00 (at the age of 59 year old) as dose 2, single for COVID-19 immunisation. Medical history included allergies to Sulfa products, doxycycline and was sensitive to epinephrine. Concomitant medications included alprenolol hydrochloride (ATENENOL); duloxetine hydrochloride (CYMBALTA); levothyroxine sodium (SYNTHROID) and metformin all for an unspecified indication. Prior to vaccination, patient was not diagnosed with COVID-19 and did not receive any other vaccines within 4 weeks. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: ER8730), via an unspecified route of administration, administered in left arm on 20Mar2021 13:45 (at the age of 59 year old) as dose 1, single for COVID-19 immunisation. On 10Apr2021, within 6 hours of vaccination, at 18:00, patient had rash on neck and upper chest, where rash on neck burns. Since the vaccination, the patient had not been tested for COVID-19. No treatment was received for the events. The outcome of the event rash was not recovered and of burning sensation was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds: Pfizer, Inc. EUA 027034

Current Illness:

ID: 1740445
Sex: F
Age:
State: FL

Vax Date: 04/16/2021
Onset Date: 04/17/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210417; Test Name: Blood pressure; Result Unstructured Data: Test Result:High 152/103; Comments: It's normally 128/88 or 130/90

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: My blood pressure was high the next day 152/103. It's normally 128/88 or 130/90; This is a spontaneous report received from a contactable other-healthcare professional (patient). A 61-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Unknown), via an unspecified route of administration, administered in Arm Left on 16Apr2021 11:00 (at the age of 61-years-old) as dose 1, single for COVID-19 immunisation. Medical history included blood cholesterol increased from an unknown date and unknown if ongoing. Concomitant medications included atorvastatin calcium (LIPITOR), celecoxib (CELEBREX) taken for an unspecified indication, start and stop date were not reported. The patient previously took demerol and experienced drug hypersensitivity. Patent received vaccine facility in pharmacy or drug store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, was the patient did not diagnosed with COVID-19. Since the vaccination, did not patient been tested for COVID-19. The patient experienced my blood pressure was high the next day 152/103. it's normally 128/88 or 130/90 on 17Apr2021 06:00. No treatment was received for the events. The patient underwent lab tests and procedures which included blood pressure measurement: high 152/103 (It's normally 128/88 or 130/90) on 17Apr2021. The outcome of the events was reported as unknown. No follow-up attempts are possible, information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1740446
Sex: M
Age:
State: FL

Vax Date: 03/27/2021
Onset Date: 04/26/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Today is the second day that the Gland under my right arm is very swollen. It is the size of a Golf Ball.; This is a spontaneous report from a contactable consumer (patient). A 53-year-old male patient received bnt162b2 (PFIZER BIONTECH COVID-19 MRNA VACCINE Solution for injection Lot Number: EP7533) via an unspecified route of administration in arm left on 27Mar2021 12:30 as dose 1, single and dose 2 (Lot Number: EW0161) via an unspecified route of administration in arm right on 27Mar2021 as dose 2, single (age at vaccination: 53 years) for COVID-19 immunisation. Medical history included none relevant history. Concomitant medications included sulfamethoxazole, trimethoprim (SMZ-TMP DS); ibuprofen (IBUROFEN); tadalafil (TADAFIL); phenazopyridine (PHENAZOPYRIDINE), all taken for an unspecified indication, start and stop date were not reported. No other vaccine in four weeks. No COVID prior vaccination and did not tested COVID post vaccination. No known allergies. On 26Apr2021 16:00 PM, the patient experienced that today is the second day that the gland under my right arm is very swollen. It is the size of a golf ball. No treatment was received. The clinical outcome of the events was not resolved. No follow-up attempts are possible. No further information is expected.

Other Meds: Pfizer, Inc. EUA 027034

Current Illness:

ID: 1740447
Sex: M
Age:
State: ME

Vax Date: 04/18/2021
Onset Date: 04/18/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210406; Test Name: PCR; Test Result: Positive; Comments: Nasal Swab; Test Date: 20210416; Test Name: PCR; Test Result: Positive; Comments: Nasal Swab

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: injection site pain; great difficulty sleeping due to severe joint pain; great difficulty sleeping due to severe joint pain; severe headache & severe muscle pain; severe headache & severe muscle pain; fatigue; my lymph node under my left armpit was the size of a softball while the lymph node under my right armpit was the size of a golf ball.; This is a spontaneous report from a contactable consumer or other non healthcare professional. A 60 year old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 18Apr2021 (Batch/Lot Number: ER8735) as DOSE 2, SINGLE for COVID-19 immunisation. Historical vaccine included bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 28Apr2021 (Batch/Lot Number: ER8737) as DOSE 1, SINGLE for COVID-19 immunisation. Medical history included restless legs syndrome from an unknown date and unknown if ongoing, hypersensitivity from an unknown date and unknown if ongoing, Severe allergy to poison ivy. Concomitant medication(s) included clonazepam (CLONAZEPAM) taken for an unspecified indication, start and stop date were not reported. The patient experienced injection site pain on 18Apr2021 12:30 with outcome of recovered with sequelae, great difficulty sleeping due to severe joint pain causing insomnia non-serious on 18Apr2021 12:30 with outcome of recovered with sequelae, great difficulty sleeping due to severe joint pain causing arthralgia on 18Apr2021 12:30 with outcome of recovered with sequelae, severe headache & severe muscle pain on 18Apr2021 12:30 with outcome of recovered with sequelae, severe headache & severe muscle pain causing myalgia on 18Apr2021 12:30 with outcome of recovered with sequelae, fatigue on 18Apr2021 12:30 with outcome of recovered with sequelae , The lymph node under his left armpit was the size of a softball while the lymph node under my right armpit was the size of a golf ball causing lymphadenopathy on 18Apr2021 12:30 with outcome of recovered with sequelae. The patient underwent lab tests and procedures which included polymerase chain reaction with positive result on 06Apr2021 for nasal Swab and polymerase chain reaction with positive result on 16Apr2021 for nasal Swab. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1740448
Sex: F
Age:
State: CA

Vax Date: 04/29/2021
Onset Date: 04/30/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Fever up to 101 degrees fahrenheit; Muscle aches; headache; fatigue; lymph node swollen to size of golf ball under shot arm; sore arm; This is a spontaneous report from a contactable consumer (patient). A 45 years old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EW0175) via an unspecified route, administered in Left Arm on 29Apr2021 at 13:15 (45-year-old vaccination) as Dose 2, Single for Covid-19 immunization. The patient was non-pregnant. The patient's medical history included current subacute thyroiditis, endometriosis. The patient's concomitant medication(s) included ascorbic acid (VITAMIN C), VITAMIN D3, loratadine and ascorbic acid; biotin; calcium pantothenate; cyanocobalamin; folic acid; nicotinic acid; pyridoxine hydrochloride; riboflavin; thiamine hydrochloride; tocopheryl acetate (MULTIVITAMIN). The patient previously took avelox, prednisone, singulair and experienced allergies for all past drugs. The patient had not received any other vaccine within 4 weeks prior vaccination. The patient was neither tested for Covid prior vaccination nor post vaccination. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: ER8729) via an unspecified route, administered in Left Arm on 08Apr2021 at 16:30 (45-year-old vaccination) as Dose 1, Single for Covid-19 immunization. On 30Apr2021 at 02:00 AM, the patient had experienced fever up to 101 degrees Fahrenheit, muscle aches, headache, fatigue (after 18-36 hours of vaccination) and (after 36-96 hours) lymph node swollen to size of golf ball under shot arm, sore arm. No treatment received for resulted events. The outcome of the events was recovering. No follow-up attempts are possible. No further information was expected.

Other Meds:

Current Illness:

ID: 1740449
Sex: F
Age:
State: VA

Vax Date: 05/06/2021
Onset Date: 05/07/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Swollen lymph nodes, soft, tender, bean sized along collar bone. All on the left side only; This is a spontaneous report from a contactable consumer (patient). A 33 years old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, 33-year-old at vaccination), via an unspecified route, administered in Left Arm on 15Apr2021 at 11:00 (Lot Number: ER8729) as a Dose 1, Single and via an unspecified route, administered in Left Arm on 06May2021 at 11:00 (Lot Number: EW0168) as a Dose 2, Single, both doses for COVID-19 immunization. The patient was non-pregnant at time of vaccination. The patient's medical history included IBS (irritable bowel syndrome). No known allergies. There were no concomitant medications within two weeks of vaccination. Facility type vaccine was reported Pharmacy or Drug Store. The patient was not tested for Covid prior vaccination. The patient had not received any other vaccine within four weeks prior vaccination. On 07May2021, the patient had experienced swollen lymph nodes in armpit, soft, tender, and about golf ball sized swollen lymph nodes, soft, tender, bean sized along collar bone. All on the left side only. These adverse events did not resulted in emergency room/physician office visit. No treatment was received for resulted events. The patient was not tested for Covid post vaccination. The outcome of the events was not recovered. No follow-up attempts are possible. No further information was expected.

Other Meds:

Current Illness:

ID: 1740450
Sex: F
Age:
State: MD

Vax Date: 05/09/2021
Onset Date: 05/10/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210510; Test Name: fever; Result Unstructured Data: Test Result:100.8 Fahrenheit; Comments: low fever of 100.8 F

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: significant swelling up and down the arm that had the injection; pain in the elbow; A low fever of 100.8 F; body aches in the lower back and knee; body aches in the lower back and knee; painful lymph node swelling in the same arm as the injection is present with significant fluid (more than a golf ball size); painful lymph node swelling in the same arm as the injection is present with significant fluid (more than a golf ball size); This is a spontaneous report from a contactable consumer (patient). A 42-year-old female non-pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EW0170, Expiration date: not reported), via an unspecified route of administration in arm left on 09May2021 at 10:15 AM (at the age of 42-year-old) as a dose 2, single for COVID-19 immunization. The patient's medical history included birth control. Past drug event included oxycodone hydrochloride;oxycodone terephthalate;paracetamol [PERCOCET] and experienced allergy. The patient's concomitant medications in two weeks included ethinylestradiol, norethisterone acetate (JUNEL), taken for birth control. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: ER8731, Expiration date: not reported), via an unspecified route of administration in arm left on 18Apr2021 at 10:30 AM (at the age of 41-year-old) as a dose 1, single for COVID-19 immunization. It was reported that, the patient was not pregnant at time of vaccination. Other vaccine in four weeks was reported as no. No covid prior vaccination and no covid tested post vaccination. On 10May2021, the day after the vaccine, significant swelling up and down the arm that had the injection, with pain in the elbow. A low fever of 100.8 F and body aches in the lower back and knee occurred. 48 hrs after receiving the vaccine, painful lymph node swelling in the same arm as the injection was present with significant fluid (more than a golf ball size). This pain has persisted even with 400 mg of ibuprofen taken daily. Treatment was not received for the events. On 10May2021, the patient underwent lab tests and procedures which included fever (body temperature), resulted as 100.8 Fahrenheit, low fever of 100.8 F. The outcome of the events was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1740451
Sex: M
Age:
State: IL

Vax Date: 06/04/2021
Onset Date: 06/05/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210605; Test Name: Chest Pains; Result Unstructured Data: Test Result:7/8; Comments: Chess Pains of 7/8 over two days.

Allergies:

Symptom List: Nausea

Symptoms: Chest Pains of 7/8 over two days; Pain in my back; Pain in my left arm; Tired after biking 10-15 miles. I usually do 30-40 and not tried.; This is a spontaneous report from a contactable consumer (patient). A 72-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration on 04Jun2021 14:15 (at the age of 72-years-old) as dose number unknown, single for COVID-19 immunisation. Medical history included mild asthma and known penicillin allergy. There were no concomitant medications. On 05Jun2021 18:00, the patient experienced chest pains of 7/8 over two days. Pain in my left arm and back. Tired after biking 10-15 miles. He usually does 30-40 and not tired. The patient underwent lab tests and procedures which included chest pain intensity 7/8 over two days on 05Jun2021. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and not tested for Covid-19 post vaccination. It was unknown if patient had treatment for the events. The outcome of the events was resolving. The lot number for the vaccine, (BNT162B2), was not provided and will be requested during follow-up.

Other Meds:

Current Illness:

ID: 1740452
Sex: F
Age:
State: FL

Vax Date: 06/28/2021
Onset Date: 06/29/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Extreme pain in back and stomach after second dose; Extreme pain in back and stomach after second dose; couldn't barely walk day after; eased off pain still there; This is a spontaneous report from a contactable consumer (patient) or other non hcp. A 37-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in Arm Left on 28Jun2021 16:45 (at the age of 37-years-old) as dose 2, single for COVID-19 immunization. Medical history included contraception from an unknown date and unknown if ongoing. Concomitant medication included butalbital, caffeine, paracetamol (FIORICET) taken for contraception, start and stop date were not reported. The patient previously took macrobid [clarithromycin] and experienced drug hypersensitivity. Previously patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in Arm Left on 07Jun2021 05:45 (at the age of 37-years-old) as dose 1, single for COVID-19 immunization. No COVID prior to the vaccination. COVID not tested post vaccination. On 29Jun2021 07:00, the patient experienced extreme pain in back and stomach after second dose, couldn't barely walk day after, eased off pain still there. The outcome of the event eased off pain still there was recovering. The outcome of the events extreme pain in back and stomach after second dose, couldn't barely walk day after was unknown. No Follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1740453
Sex: F
Age:
State: FL

Vax Date: 06/15/2021
Onset Date: 06/17/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Chest pain; difficulty breathing; This is a spontaneous report from a contactable consumer (patient). A 35-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, in Arm Left, on 15Jun2021 at 04:00 PM (age at vaccination: 35 years), as a single dose for COVID-19 immunization at Pharmacy or Drug Store. The patient was not pregnant at the time of vaccination. The patient's medical history and concomitant medications were not reported. The patient did not have any known allergies. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, in Arm Left, on 25May2021 at 05:00 PM (age at vaccination: 35 years), as a single dose for COVID-19 immunization at Pharmacy or Drug Store. The patient did not receive any other vaccine in four weeks. The patient was not diagnosed with COVID prior vaccination. The patient was not tested for COVID post vaccination. On 17Jun2021 at 08:00 AM, the patient experienced chest pain and difficulty breathing. The adverse events were resulted in doctor or other healthcare professional office/clinic visit. The patient was not received treatment for the events. Outcome of the events was not recovered. The lot number for [BNT162B2], was not provided and will be requested during follow-up.

Other Meds:

Current Illness:

ID: 1740454
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Missed periods for three months; Headache for about 5 weeks; This is a spontaneous report from a contactable consumer (patient). A 47-year-old (Adult 18-64 Years) non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number and Expiration date was not reported) via an unspecified route of administration, on 19Mar2021 (the day of vaccination), as dose 2, single for COVID-19 immunisation. The patient medical history and concomitant medications was not reported. The patient had no other medical history and no known allergies. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number and Expiration date was not reported) via an unspecified route of administration in left arm, on 19Mar2021 (at the age of 47-year-old), as dose 1, single for COVID-19 immunisation. There was no other vaccine in four weeks. There were no other medications in two weeks. The patient had no covid prior vaccination and not test covid post vaccination. On an unspecified date, consumer stated that she missed periods for three months after second dose of vaccine. She had no explanation for why she missed her period. Never missed in the past and returned in June. Headache for about 5 weeks after second dose. She didn't take pain relief before or after vaccine. Took pain relief about 3 weeks after second dose because headache was persistent. AE resulted in doctor or other healthcare professional office/clinic visit. The patient received treatment for AE included pain medications for headache, didn't work. Outcome of the events was unknown. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1740455
Sex: F
Age:
State: NJ

Vax Date: 03/25/2021
Onset Date: 03/25/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: She had flushing on the same side of her face on that she got the vaccine; This is a spontaneous report from a contactable consumer or other non hcp. A female patient of an unspecified age received second dose bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration in Arm Right on 25Mar2021 08:30 as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 25Mar2021 13:00 the patient experienced she had flushing on the same side of her face on that she got the vaccine. The outcome of the event flushing was recovering. Information about lot/batch number not provided. Requested during follow up.

Other Meds:

Current Illness:

ID: 1740456
Sex: F
Age:
State: TX

Vax Date: 09/17/2021
Onset Date: 09/17/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: patient received Daptacel instead of Adacel with no reported adverse event; 37 year old patient received Daptacel instead of Adacel with no adverse event; Initial information was received on 21-Sep-2021 regarding an unsolicited valid non-serious case received from other health care professional and consumer/non-healthcare professional via Medical information (under reference number - 00778953). This case involves a 37-year-old female patient who was accidentally vaccinated with DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] instead of the DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE [ADACEL] with no adverse event (Wrong product administered) (Product administered to patient of inappropriate age). The patient's medical history, past medical treatment(s), concomitant therapy, vaccination(s) and family history were not provided. On 17-Sep-2021, the patient received a dose of suspect DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination (Wrong product administered) (Product administered to patient of inappropriate age). It was reported "caller asks when can the Adacel be given? Also, when would the patient get an Adacel booster?." There were no laboratory data/results available. It was case of an actual medication error due to wrong vaccine administered and inappropriate age at vaccine administration (latency was on same day) At the time of report, no adverse events were reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Other Meds:

Current Illness:

ID: 1740457
Sex: F
Age: 18
State:

Vax Date: 09/12/2021
Onset Date: 09/12/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Red rash on arm, it is red, hot, and swollen; Red rash on arm, it is red, hot, and swollen; Red rash on arm, it is red, hot, and swollen; This spontaneous case was received on 15-Sep-2021 from non-health professional (consumer) via Med Communications (reference number: SEQW21-02335) and concerned an 18-year-old female patient. The patient's concurrent conditions included celiac disease, eosinophilic esophagitis (EoE), and allergy to wheat, flour and chicken. The patient was not taking any concomitant medications. On 12-Sep-2021, the patient was vaccinated with Flucelvax Quadrivalent (influenza vaccine, subunit influenza virus vaccine polyvalent, dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid) for influenza prophylaxis. The batch number reported was 308451 and expiry date 30-Jun-2022. On the same day, after receiving Flucelvax Quadrivalent, the patient experienced red rash on her arm and it was red, hot and swollen. The patient did not receive any treatment for the events. At the time of initial reporting on 15-Sep-2021, the patient had not recovered from the events. The reporter assessed the case as non-serious. Company comment: An 18-year-old patient was vaccinated with Flucelvax Quadrivalent. On the same day, after receiving Flucelvax Quadrivalent, the patient experienced red rash on her arm and it was red, hot and swollen. Causal role of the suspect vaccine is assessed as possibly related.; Sender's Comments: An 18-year-old patient was vaccinated with Flucelvax Quadrivalent. On the same day, after receiving Flucelvax Quadrivalent, the patient experienced red rash on her arm and it was red, hot and swollen. Causal role of the suspect vaccine is assessed as possibly related.

Other Meds:

Current Illness: Celiac disease; Eosinophilic esophagitis; Flour sensitivity; Food allergy

ID: 1740458
Sex: F
Age: 61
State: AR

Vax Date: 09/10/2021
Onset Date: 09/10/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Nausea, vomiting and diarrhea; Nausea, vomiting and diarrhea; Nausea, vomiting and diarrhea; This spontaneous case was received on 17-Sep-2021 from other health professional (pharmacist) via Agency (reference number: SEQW21-02439) and concerned a 61-years-old female patient. The patient's medical history was not reported. The patient's concomitant medication included Plavix (clopidogrel bisulfate), Hydrocodone (hydrocodone bitartrate), Lipitor (atorvastatin calcium), Protonix (pantoprazole sodium sesquihydrate), Losartan (losartan potassium), Amlodipine (amlodipine besilate), chlorthalidone (reported as Chlortalidone), Cymbalta (duloxetine hydrochloride) all used for an unreported indication. On 10-Sep-2020, the patient was vaccinated with Afluria Quadrivalent (influenza vaccine; dose: 0.5 ml, route of administration: intramuscular and anatomical location: deltoid) for influenza prophylaxis. The batch number was P100360857 and expiry date was reported as 30-Jun-2022. On the same date after receiving Afluria Quadrivalent, the patient had severe nausea, vomiting and diarrhea. On 12-Sep-2021, the patient recovered from the events of 'nausea', 'vomiting' and 'diarrhoea'. The reporter did not provide causality assessment. The reporter assessed the case as non-serious. Company Comment: Events 'nausea', 'vomiting' and 'diarrhoea' are considered as related to Afluria Quadrivalent.; Sender's Comments: Events 'nausea', 'vomiting' and 'diarrhoea' are considered as related to Afluria Quadrivalent.

Other Meds: Plavix; Hydrocodone; Lipitor; Protonix; Losartan; Amlodipine; Chlorthalidone; Cymbalta

Current Illness:

ID: 1740459
Sex: M
Age: 59
State: AR

Vax Date: 09/10/2021
Onset Date: 09/10/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Nausea, vomiting and diarrhea; Nausea, vomiting and diarrhea; Nausea, vomiting and diarrhea; This spontaneous case was received on 17-Sep-2021 from pharmacist via Med Communications (reference number: SEQW21-02439) and concerned a 59-year-old, male patient. The patient's medical history was not reported. The patient's concomitant medication included Hydrocodone (hydrocodone bitartrate), nifedipine, Cymbalta (duloxetine hydrochloride) and Losartan (losartan potassium), all used for unreported indication. On 10-Sep-2021, the patient was vaccinated with Afluria Quadrivalent (influenza vaccine; dose: 0.5 ml, route of administration: intramuscular and anatomical location: deltoid) for influenza prophylaxis. The batch number reported was P100360857 and expiry date was 30-Jun-2022. On the same date, after receiving Afluria Quadrivalent, the patient had severe nausea, vomiting and diarrhea. On 12-Sep-2021, the patient recovered from the events. The reporter did not provide a causality assessment. The reporter assessed the case as non-serious. This case is linked to the case 202103051 (the same reporter). Company comment: Events nausea, vomiting and diarrhea are considered as related to Afluria Quadrivalent.; Sender's Comments: Events nausea, vomiting and diarrhea are considered as related to Afluria Quadrivalent.

Other Meds: Hydrocodone; Nifedipine; Cymbalta; Losartan

Current Illness:

Date Died:

ID: 1740515
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: passed away; This case was reported by a consumer via media and described the occurrence of unknown cause of death in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, less than a day after receiving Shingles vaccine, the patient experienced unknown cause of death (serious criteria death and GSK medically significant). On an unknown date, the outcome of the unknown cause of death was fatal. The reported cause of death was unknown cause of death. The reporter considered the unknown cause of death to be related to Shingles vaccine. Additional details were reported as follows: The patient was reporter's sister in law. The age at vaccination was not reported. The patient passed away from getting the Shingles shot during the night she received it. The follow-up would not possible as no contact details were available.; Reported Cause(s) of Death: Unknown cause of death

Other Meds:

Current Illness:

ID: 1740518
Sex: M
Age: 12
State: VA

Vax Date: 09/15/2021
Onset Date: 09/15/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: administered infanrix/, Date of birth Jul 28th 2009; administered infanrix/ Boostrix was the vaccine indicated; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 12-year-old male patient who received DTPa (Infanrix) (batch number 7EC55, expiry date 29th April 2023) for prophylaxis. Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 15th September 2021, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. On 15th September 2021, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: A health care professional administered Infanrix to a patient of age 12 years old, instead Boostrix was the vaccine indicated for the patient, which led to inappropriate age at vaccine administration and wrong vaccine administered. The reporter consented to follow up. This case was 1 of 7 linked cases reported by same reporter for different patients.; Sender's Comments: US-GLAXOSMITHKLINE-US2021201377:same reporter US-GLAXOSMITHKLINE-US2021201373:same reporter US-GLAXOSMITHKLINE-US2021201375:same reporter US-GLAXOSMITHKLINE-US2021201376:same reporter US-GLAXOSMITHKLINE-US2021201380:same reporter US-GLAXOSMITHKLINE-US2021201379:same reporter

Other Meds:

Current Illness:

ID: 1740519
Sex: M
Age: 13
State: VA

Vax Date: 09/15/2021
Onset Date: 09/15/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: administered infanrix /, Date of birth Feb 13th 2008; administered infanrix, /Boostrix was the vaccine indicated; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 13-year-old male patient who received DTPa (Infanrix) (batch number 7EC55, expiry date 29th April 2023) for prophylaxis. Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 15th September 2021, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. On 15th September 2021, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: A health care professional administered infanrix to a patient of age 13 years old, instead Boostrix was the vaccine indicated for the patient, which led to inappropriate age at vaccine administration and wrong vaccine administered. The reporter consented to follow up. This case was 1 of 7 linked cases reported by same reporter for different patients.; Sender's Comments: US-GLAXOSMITHKLINE-US2021201373:same reporter US-GLAXOSMITHKLINE-US2021201375:same reporter US-GLAXOSMITHKLINE-US2021201376:same reporter US-GLAXOSMITHKLINE-US2021201380:same reporter US-GLAXOSMITHKLINE-US2021201379:same reporter US-GLAXOSMITHKLINE-US2021201378:same reporter

Other Meds:

Current Illness:

ID: 1740520
Sex: M
Age: 13
State: VA

Vax Date: 09/15/2021
Onset Date: 09/15/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: administered infanrix/ Date of birth Mar 13th 2008; administered infanrix/ Boostrix was the vaccine indicated; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 13-year-old male patient who received DTPa (Infanrix) (batch number 7EC55, expiry date 29th April 2023) for prophylaxis. Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 15th September 2021, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. On 15th September 2021, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: A health care professional administered infanrix to a patient of age 13 years old, instead Boostrix was the vaccine indicated for the patient, which led to inappropriate age at vaccine administration and wrong vaccine administered. The reporter consented to follow up. This case was 1 of 7 linked cases reported by same reporter for different patients.; Sender's Comments: US-GLAXOSMITHKLINE-US2021201378:same reporter US-GLAXOSMITHKLINE-US2021201377:same reporter US-GLAXOSMITHKLINE-US2021201373:same reporter US-GLAXOSMITHKLINE-US2021201375:same reporter US-GLAXOSMITHKLINE-US2021201376:same reporter US-GLAXOSMITHKLINE-US2021201380:same reporter

Other Meds:

Current Illness:

ID: 1740521
Sex: F
Age:
State: CA

Vax Date:
Onset Date: 03/02/2021
Rec V Date: 09/28/2021
Hospital: Y

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: GERD; hypertension; Hypothyroidism; Mayor depression disorder; Hyperparathyroidism secondary; Had pneumonia after the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PNEUMONIA (Had pneumonia after the vaccine), GASTROOESOPHAGEAL REFLUX DISEASE (GERD ), HYPERTENSION (hypertension ), HYPOTHYROIDISM (Hypothyroidism ), DEPRESSION (Mayor depression disorder ) and HYPERPARATHYROIDISM SECONDARY (Hyperparathyroidism secondary) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced GASTROOESOPHAGEAL REFLUX DISEASE (GERD ) (seriousness criterion hospitalization), HYPERTENSION (hypertension ) (seriousness criterion hospitalization), HYPOTHYROIDISM (Hypothyroidism ) (seriousness criteria hospitalization and medically significant), DEPRESSION (Mayor depression disorder ) (seriousness criterion hospitalization) and HYPERPARATHYROIDISM SECONDARY (Hyperparathyroidism secondary) (seriousness criterion hospitalization). On an unknown date, the patient experienced PNEUMONIA (Had pneumonia after the vaccine) (seriousness criterion medically significant). At the time of the report, PNEUMONIA (Had pneumonia after the vaccine), GASTROOESOPHAGEAL REFLUX DISEASE (GERD ), HYPERTENSION (hypertension ), HYPOTHYROIDISM (Hypothyroidism ), DEPRESSION (Mayor depression disorder ) and HYPERPARATHYROIDISM SECONDARY (Hyperparathyroidism secondary) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication use information was not provided by reporter. Treatment medication use information was not provided by reporter. Company comment: This case concerns a female patient of an unknown age with no previous relevant medical history, who experienced the unexpected event of pneumonia. The events occurred on an unknown number of days after the first dose of mRNA-1273. The rechallenge was positive, as the events happened after the first dose and second dose have repeated. The reporter assessed the events as possible. The benefit-risk relationship of mRNA-1273 is not affected by this report. This case was linked to MOD-2021-325636, MOD-2021-325515 (Patient Link).; Sender's Comments: This case concerns a female patient of an unknown age with no previous relevant medical history, who experienced the unexpected event of pneumonia. The events occurred on an unknown number of days after the first dose of mRNA-1273. The rechallenge was positive, as the events happened after the first dose and second dose have repeated. The reporter assessed the events as possible. The benefit-risk relationship of mRNA-1273 is not affected by this report.

Other Meds:

Current Illness:

ID: 1740522
Sex: F
Age:
State:

Vax Date:
Onset Date: 04/01/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: CONSTANT LEG CRAMPS; COMMON SIDE EFFECTS; CONSTANT PINCHES; SIDE OF THE ARM OF JAB STILL HURTS; LOST STRENGTH IN ARM (WAS NOT ABLE TO OPEN WATER BOTTLE AS USED TO BEFORE); This spontaneous report received from a consumer concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient did not have potential Guillain barre syndrome and blood clot situation before getting the vaccine. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the patient experienced constant leg cramps. On APR-2021, the patient experienced common side effects. On APR-2021, the patient experienced constant pinches. On APR-2021, the patient experienced side of the arm of jab still hurts. On APR-2021, the patient experienced lost strength in arm (was not able to open water bottle as used to before). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from side of the arm of jab still hurts, and the outcome of common side effects, lost strength in arm (was not able to open water bottle as used to before), constant leg cramps and constant pinches was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment is not required as per standard procedure as case assessed as non-serious.

Other Meds:

Current Illness:

Date Died:

ID: 1740523
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: DEATH; BREAKTHROUGH INFECTION; SUSPECTED CLINICAL VACCINATION FAILURE; This spontaneous report received from a physician via a company representative concerned a male of unspecified age, race and ethnic origin. The patient's height, and weight were not reported. The patient's past medical history included: hypertension, dyslipidemia, type 2 diabetes, and Chronic renal failure (CKD). The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose, 1 total administered on unspecified therapy start date for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced breakthrough infection with Covid-19 vaccine ad26.cov2.s(suspected clinical vaccine failure), and died. On an unspecified date, the patient died from unknown cause of death. It was unspecified if an autopsy was performed. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The outcome of breakthrough infection and suspected clinical vaccination failure was not reported. This report was serious (Death, and Other Medically Important Condition).; Sender's Comments: 20210949213-covid-19 vaccine ad26.cov2.s-Suspected Clinical Vaccination Failure. This event(s) is considered not related. The event(s) has an compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS 20210949213-covid-19 vaccine ad26.cov2.s-Death, breakthrough infection. This event(s) is considered unassessable. The event(s) has an compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s); Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Other Meds:

Current Illness: Chronic renal failure; Dyslipidemia; Hypertension; Type II diabetes mellitus

ID: 1740524
Sex: F
Age:
State: LA

Vax Date:
Onset Date: 03/31/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: STROKE; LOW GRADE FEVER; This spontaneous report received from a patient concerned a 33 year old White and not Hispanic or Latino female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry: Unknown) dose was not reported, 1 total administered on left arm on 31-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 31-MAR-2021, the patient experienced low grade fever, and was better in less than 24 hours. On 24-MAY-2021, the patient had stroke. The doctors could not relate the stroke to the vaccine. Patient was told that it was an anti-inflammatory disease that could happen from a cold, a virus or a vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from low grade fever, and the outcome of stroke was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0-20210949893-Covid-19 vaccine ad26.cov2.s- Stroke. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.

Other Meds:

Current Illness:

ID: 1740525
Sex: F
Age:
State: GA

Vax Date:
Onset Date: 09/24/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: SUBCONJUNCTIVAL HEMORRHAGE; ALLERGIC REACTION; TINGLING SENSATION BACK TO LEFT KNEE; This spontaneous report received from a patient concerned a 59 year old female with unknown race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin was not reported, batch number: 1822809, and expiry: 07-MAR-2022) dose was not reported, 1 total administered at left arm on 24-SEP-2021 for prophylactic vaccination. No concomitant medications were reported. On 24-SEP-2021, the patient experienced subconjunctival hemorrhage, allergic reaction, tingling sensation back to left knee. The patient had no immediate reaction following injection. The patient had developed once a red spot to the eye cornea and it was described as a subconjunctival hemorrhage. The patient denied any respiratory distress or immediate emergency and was aware about clotting issues with hemorrhage of eye. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the subconjunctival hemorrhage, allergic reaction and tingling sensation back to left knee was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210949991-covid-19 vaccine ad26.cov2.s -Subconjunctival hemorrhage. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Other Meds:

Current Illness:

ID: 1740526
Sex: F
Age:
State: NC

Vax Date:
Onset Date: 09/05/2021
Rec V Date: 09/28/2021
Hospital: Y

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210905; Test Name: COVID-19 virus test; Result Unstructured Data: Positive; Test Name: Blood test; Result Unstructured Data: unknown

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: PNEUMONIA; SUSPECTED COVID-19 INFECTION; SUSPECTED CLINICAL VACCINATION FAILURE; This spontaneous report received from a patient concerned a 43 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: bipolar, diabetic, high cholesterol, penicillin allergy, and sulpha allergy. The patient experienced drug allergy when treated with lamotrigine. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A21A, and expiry: 21-SEP-2021) dose was not reported, 1 total, administered on 02-AUG-2021 for prophylactic vaccination. No concomitant medications were reported. On 05-SEP-2021, the patient experienced suspected clinical vaccination failure as patient test positive for Covid-19. On an unspecified date, the patient experienced pneumonia, could not move, and could not do anything. Treatment medications (dates unspecified) included: lorazepam, and mirtazapine. Patient was administered Ativan and also treated with Remeron for 2 weeks. On 05-SEP-2021, the patient experienced weakness, and suspected covid-19 infection, and was hospitalized. The patient was hospitalized for 14 days and discharged on 18-SEP-2021. Patient felt week and deconditioned. They tied patient to the bed for 2 weeks. Patient stated that she could not move and could not do anything for herself and still can't but patient was trying. They did a ton of blood work but patient didn't remember any. Patient mentioned that she was really sick. Patient was calling to try to get Levaquin for pneumonia. Laboratory data (dates unspecified) included: Blood test (NR: not provided) with unknown result , and on 05-SEP-2021, COVID-19 virus test (NR: not provided) Positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the suspected clinical vaccination failure, pneumonia and suspected covid-19 infection was not reported. This report was serious (Hospitalization Caused / Prolonged). This report was associated with product quality complaint: 90000194723.; Sender's Comments: V0: 20210950464- Covid-19 vaccine ad26.cov2.s- Suspected clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS 20210950464- Covid-19 vaccine ad26.cov2.s- Pneumonia, suspected covid-19 infection. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Other Meds:

Current Illness: Bipolar disorder; Diabetic; High cholesterol; Penicillin allergy; Sulfonamide allergy

ID: 1740527
Sex: U
Age:
State:

Vax Date:
Onset Date: 09/23/2021
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210923; Test Name: COVID-19 virus test; Result Unstructured Data: Positive

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Suspected Clinical Vaccination Failure; COVID-19 INFECTION; This spontaneous report received from a patient via social media via a company representative concerned a patient of unspecified age, sex, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of administration not reported, batch number: Unknown) dose was not reported, with frequency as 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On 23-SEP-2021, the patient tested positive for Covid (covid-19 infection). Physician would not order antibody as far as patient knew. Patient had green which was nasty and was congested all day (suspected clinical vaccination failure). Laboratory data included: COVID-19 virus test (NR: not provided) Positive. The action taken with covid-19 vaccine was not applicable. The outcome of the suspected clinical vaccination failure and covid-19 infection was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint.; Sender's Comments: V0. 20210950996-COVID-19 VACCINE - Suspected clinical vaccination failure. This event is considered not related. The event has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the events than the drug. Specifically: SPECIAL SITUATIONS

Other Meds:

Current Illness:

ID: 1740528
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Name: COVID-19 virus test; Result Unstructured Data: no covid (negative)

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: TWO STROKES; This spontaneous report received from a patient via social media concerned a patient of unspecified age, sex, unknown race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) 1 total, dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced two strokes and felt that people only told the good stuff and no one told the bad stuff. Laboratory data (dates unspecified) included: COVID-19 virus test (NR: not provided) no covid (negative). The action taken with covid-19 vaccine was not applicable. The outcome of two strokes was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20210950516.; Sender's Comments: V0-20210951067-Covid-19 vaccine - Two Stroke. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am